BioBusiness 2008
|
As the global bio-partnering calendar becomes more and more complicated and good deals become harder to find, BioBusiness stands out as the only event which has maintained credibility and quality throughout its 6-year history. BioBusiness delegates are senior decision makers who attend the conference for 3 days of intensive networking, learning and deal-making. If you want to meet the right people from the world’s most innovative biotechs and foremost pharmaceutical companies, you need to be at BioBusiness 2008.
If you are interested in finding out more about BioBusiness 2008, please email us at biobusiness@wbr.co.uk or call us at +44 (0)20 7368 9465.
Partnering Made Easy: One-To-One Meeting Rooms, 26th-28th February
How do I book a room?
Register for BioBusiness 2008 and receive your own unique username and password which allow you to schedule your meetings online. On the website, you will find the list of your fellow attendees with their contact details and a timetable of available meeting room slots. Select a partners, invite them to meet with you and, once they have agreed, you can book your room. If you have any questions, please contact Karen Freemantle, karen.freemantle@wbr.co.uk or call +44 (0)20 7368 9465
Key Topics:
- BioBusiness is the most senior and exclusive conference in the industry, meaning you can spend 100% of your networking time with the people that matter
- A high-calibre speaker line-up combining business development and scientific expertise
- Hear from both sides of recent alliances in 9 of the most exciting headline deals of the last 12 months
- Take part in our highly effective one-to-one meetings to renew existing relationships and build new ones
- Make valuable business contacts and exchange ideas at our informal champagne roundtables
Confirmed Speakers For 2008 Include:
![]() |
Bob Nelson, Senior Research Fellow, Global R&D, Pfizer |
Martin Braddock, Director, Discovery Bioscience, AstraZeneca |
|
![]() |
Christopher Seaton, Senior Vice President, Global Transactions, Bayer |
![]() |
Joseph Messina, Senior Director, Licensing, Wyeth |
![]() |
Mark Strobeck, Vice President, Business Development, GSK |
![]() |
Ayad Abdul-Ahad, Vice President, International Medical Affairs, Biogen Idec |
| Bharat Chowrira, Worldwide Licensing & External Research, Merck |
![]() |
Karen Heubscher, Global Head, Business Development & Licensing, Novartis Vaccines & Diagnostics | |
| Reinhard Ambros, Executive Director, Novartis Venture Fund |
![]() |
David Colpman, Senior Vice President, Business Development, Shire Pharmaceuticals |
|
![]() |
Graham Brazier, Vice President & Head of Business Development, BMS |
![]() |
Gad Bitton, Global Alliance Director, Pharma Partnering, Roche |
Sponsored By
















